423 related articles for article (PubMed ID: 20836727)
1. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
Moradi S; Mollabashi M; Kerman SR
Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
[TBL] [Abstract][Full Text] [Related]
2. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
4. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
Hu W; Qiao J; Yang Y; Wang L; Li R
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
[TBL] [Abstract][Full Text] [Related]
5. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
6. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome.
Wu Y; Zhang J; Wen Y; Wang H; Zhang M; Cianflone K
Fertil Steril; 2009 Jan; 91(1):213-9. PubMed ID: 18206145
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in adolescents with polycystic ovary syndrome.
Vrbíková J; Zamrazilová H; Sedláčková B; Šnajderová M
Gynecol Endocrinol; 2011 Oct; 27(10):820-2. PubMed ID: 20807165
[TBL] [Abstract][Full Text] [Related]
9. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
10. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
13. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan.
Wu DM; Chu NF; Shen MH; Wang SC
Clin Biochem; 2006 Aug; 39(8):810-5. PubMed ID: 16814764
[TBL] [Abstract][Full Text] [Related]
14. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.
Xita N; Papassotiriou I; Georgiou I; Vounatsou M; Margeli A; Tsatsoulis A
Metabolism; 2007 Jun; 56(6):766-71. PubMed ID: 17512308
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
16. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
17. Plasma visfatin level in women with polycystic ovary syndrome.
Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Abdullah AR; Hasan HA; Raigangar VL
Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
[TBL] [Abstract][Full Text] [Related]
19. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
